Fundraising Fox

Andrew ElBardissi

Investor

Partner at Deerfield Management Company

New York, New York

Writes $10M – $50M checks · typically $25M

About

A partner on Deerfield's Medical Technologies team who joined in 2017, previously a principal at Longitude Capital investing in medtech and biotech and an associate in JPMorgan's healthcare investment banking practice. He is a trained surgeon with an M.D. from the Mayo Clinic, an M.P.H. and M.B.A. from Harvard, and residency training at Harvard's Brigham and Women's Hospital and Stanford.

Experience

  1. Deerfield ManagementPartnercurrent2017 — presentNew York, New York, United States
  2. Medical Microinstruments, Inc.Board Membercurrent2022 — present
  3. Aurion BiotechBoard Membercurrent2022 — present
  4. BitterootBoard Membercurrent2021 — present
  5. Adela BioBoard Membercurrent2021 — present
  6. Encodia, Inc.Board Membercurrent2020 — present
  7. Endologix LLCBoard Membercurrent2020 — present
  8. Sema4Board Membercurrent2020 — present
  9. Reprieve CardiovascularBoard Membercurrent2020 — present
  10. Element Science, Inc.Board Membercurrent2019 — present
  11. Singular GenomicsBoard Membercurrent2018 — present
  12. Axon Therapies Inc.Board Membercurrent2018 — present
  13. InCarda TherapeuticsBoard Membercurrent2018 — present
  14. CathWorksBoard Membercurrent2018 — present
  15. Epic Sciences │ The Power of ClarityBoard Membercurrent2017 — present
  16. Sollis TherapeuticsBoard Membercurrent2017 — present
  17. Acutus Medical, Inc.Board Membercurrent2017 — present
  18. FARAPULSE, Inc.Board Membercurrent2017 — present
  19. V-WaveBoard Membercurrent2017 — present
  20. Conventus-Flower OrthopedicsBoard Membercurrent2017 — present

Education

  1. Harvard Business SchoolMBA, Business
  2. Harvard T.H. Chan School of Public HealthMPH, Quantitative Methods
  3. Mayo Clinic Alix School of MedicineDoctor of Medicine (M.D.), Medicine

Skills & more

Strategic PlanningAnalysisStrategyManagementHealthcareHealthcare Information TechnologyData AnalysisManagement ConsultingEntrepreneurshipBusiness StrategyFinancial ModelingCorporate Finance
+12 moreMarket ResearchCompetitive AnalysisDue DiligenceFinancial AnalysisVenture CapitalInvestmentsMedical DevicesInvestment BankingClinical ResearchMergers & AcquisitionsStart-upsPrivate Equity

From Andrew's professional profile.

Same school

Shared employers

Deals · 12

AdelaBoard seat

via Deerfield Management Company · filed Jul 2025 · $27M raise

Medical Microinstruments, Inc.Board seat

via Deerfield Management Company · filed Mar 2024 · $110M raise

NeochordBoard seat

via Deerfield Management Company · filed Nov 2022 · $6M raise

Acutus MedicalBoard seat

via Deerfield Management Company · filed Jul 2022 · $4.2M raise

Reprieve CardiovascularBoard seat

via Deerfield Management Company · filed Jun 2022 · $15M raise

Aurion BiotechBoard seat

via Deerfield Management Company · filed Apr 2022 · $26.1M raise

NXT BiomedicalBoard seat

via Deerfield Management Company · filed May 2021 · $10M raise

InCarda TherapeuticsBoard seat

via Deerfield Management Company · filed Oct 2020 · $50M raise

Element ScienceBoard seat

via Deerfield Management Company · filed Mar 2020 · $145.6M raise

Axon TherapiesBoard seat

via Deerfield Management Company · filed Feb 2019 · $15M raise

Conventus OrthopaedicsBoard seat

via Deerfield Management Company · filed Jan 2019 · $5M raise

Iowa ApproachBoard seat

via Deerfield Management Company · filed Aug 2018 · $12M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Deerfield Management Company

Network13

1 more connections

Terence Karnal

Investors connected to Andrew in public investor directories — a warm-intro map.